NCT02283242View on ClinicalTrials.gov

Galantamine Effects in Patients With Metabolic Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

February 28, 2017

Conditions
Abdominal Obesity Metabolic Syndrome
Interventions
DRUG

Galantamine

Oral use for 12 weeks

DRUG

Placebo (for galantamine)

Oral use for 12 weeks

Trial Locations (1)

05403-900

University of São Paulo, Heart Institute, Medical School, São Paulo

Sponsors
All Listed Sponsors
collaborator

University of Nove de Julho

OTHER

collaborator

Feinstein Institute for Medical Research

OTHER

lead

University of Sao Paulo

OTHER